Combined therapeutic approach: Inflammatory bowel diseases and peripheral or axial arthritis

Fabiola Atzeni, Sandro Ardizzone, Luca Bertani, Marco Antivalle, Alberto Batticciotto, Piercarlo Sarzi-Puttini

Research output: Contribution to journalArticle

Abstract

Inflammatory bowel diseases (IBDs), particularly Crohn's disease (CD) and ulcerative colitis (UC), are associated with a variety of extra-intestinal manifestations (EIMs). About 36% of IBD patients have at least one EIM, which most frequently affect the joints, skin, eyes and the biliary tract. The EIMs associated with IBD have a negative impact on patients with UC and CD, and the resolution of most of them parallels that of the active IBD in terms of timing and required therapy; however, the clinical course of EIMs such as axial arthritis, pyoderma gangrenosum, uveitis, and primary sclerosing cholangitis is independent of IBD activity. The peripheral and axial arthritis associated with IBD have traditionally been treated with simple analgesics, non-steroidal anti-inflammatory drugs, steroids, sulfasalazine, methotrexate, local steroid injections and physiotherapy, but the introduction of biological response modifiers such as tumor necrosis factor-α blockers, has led to further improvements.

Original languageEnglish
Pages (from-to)2469-2471
Number of pages3
JournalWorld Journal of Gastroenterology
Volume15
Issue number20
DOIs
Publication statusPublished - May 28 2009

Fingerprint

Inflammatory Bowel Diseases
Arthritis
Ulcerative Colitis
Crohn Disease
Therapeutics
Steroids
Pyoderma Gangrenosum
Sulfasalazine
Sclerosing Cholangitis
Uveitis
Immunologic Factors
Biliary Tract
Methotrexate
Analgesics
Anti-Inflammatory Agents
Tumor Necrosis Factor-alpha
Joints
Skin
Injections
Pharmaceutical Preparations

Keywords

  • Anti-tumor necrosis factor antagonists
  • Arthropathies
  • Inflammatory bowel disease
  • Treatment

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Atzeni, F., Ardizzone, S., Bertani, L., Antivalle, M., Batticciotto, A., & Sarzi-Puttini, P. (2009). Combined therapeutic approach: Inflammatory bowel diseases and peripheral or axial arthritis. World Journal of Gastroenterology, 15(20), 2469-2471. https://doi.org/10.3748/wjg.15.2469

Combined therapeutic approach : Inflammatory bowel diseases and peripheral or axial arthritis. / Atzeni, Fabiola; Ardizzone, Sandro; Bertani, Luca; Antivalle, Marco; Batticciotto, Alberto; Sarzi-Puttini, Piercarlo.

In: World Journal of Gastroenterology, Vol. 15, No. 20, 28.05.2009, p. 2469-2471.

Research output: Contribution to journalArticle

Atzeni, F, Ardizzone, S, Bertani, L, Antivalle, M, Batticciotto, A & Sarzi-Puttini, P 2009, 'Combined therapeutic approach: Inflammatory bowel diseases and peripheral or axial arthritis', World Journal of Gastroenterology, vol. 15, no. 20, pp. 2469-2471. https://doi.org/10.3748/wjg.15.2469
Atzeni F, Ardizzone S, Bertani L, Antivalle M, Batticciotto A, Sarzi-Puttini P. Combined therapeutic approach: Inflammatory bowel diseases and peripheral or axial arthritis. World Journal of Gastroenterology. 2009 May 28;15(20):2469-2471. https://doi.org/10.3748/wjg.15.2469
Atzeni, Fabiola ; Ardizzone, Sandro ; Bertani, Luca ; Antivalle, Marco ; Batticciotto, Alberto ; Sarzi-Puttini, Piercarlo. / Combined therapeutic approach : Inflammatory bowel diseases and peripheral or axial arthritis. In: World Journal of Gastroenterology. 2009 ; Vol. 15, No. 20. pp. 2469-2471.
@article{998e6e60f00a4f3fbc8a6c8091a67720,
title = "Combined therapeutic approach: Inflammatory bowel diseases and peripheral or axial arthritis",
abstract = "Inflammatory bowel diseases (IBDs), particularly Crohn's disease (CD) and ulcerative colitis (UC), are associated with a variety of extra-intestinal manifestations (EIMs). About 36{\%} of IBD patients have at least one EIM, which most frequently affect the joints, skin, eyes and the biliary tract. The EIMs associated with IBD have a negative impact on patients with UC and CD, and the resolution of most of them parallels that of the active IBD in terms of timing and required therapy; however, the clinical course of EIMs such as axial arthritis, pyoderma gangrenosum, uveitis, and primary sclerosing cholangitis is independent of IBD activity. The peripheral and axial arthritis associated with IBD have traditionally been treated with simple analgesics, non-steroidal anti-inflammatory drugs, steroids, sulfasalazine, methotrexate, local steroid injections and physiotherapy, but the introduction of biological response modifiers such as tumor necrosis factor-α blockers, has led to further improvements.",
keywords = "Anti-tumor necrosis factor antagonists, Arthropathies, Inflammatory bowel disease, Treatment",
author = "Fabiola Atzeni and Sandro Ardizzone and Luca Bertani and Marco Antivalle and Alberto Batticciotto and Piercarlo Sarzi-Puttini",
year = "2009",
month = "5",
day = "28",
doi = "10.3748/wjg.15.2469",
language = "English",
volume = "15",
pages = "2469--2471",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "20",

}

TY - JOUR

T1 - Combined therapeutic approach

T2 - Inflammatory bowel diseases and peripheral or axial arthritis

AU - Atzeni, Fabiola

AU - Ardizzone, Sandro

AU - Bertani, Luca

AU - Antivalle, Marco

AU - Batticciotto, Alberto

AU - Sarzi-Puttini, Piercarlo

PY - 2009/5/28

Y1 - 2009/5/28

N2 - Inflammatory bowel diseases (IBDs), particularly Crohn's disease (CD) and ulcerative colitis (UC), are associated with a variety of extra-intestinal manifestations (EIMs). About 36% of IBD patients have at least one EIM, which most frequently affect the joints, skin, eyes and the biliary tract. The EIMs associated with IBD have a negative impact on patients with UC and CD, and the resolution of most of them parallels that of the active IBD in terms of timing and required therapy; however, the clinical course of EIMs such as axial arthritis, pyoderma gangrenosum, uveitis, and primary sclerosing cholangitis is independent of IBD activity. The peripheral and axial arthritis associated with IBD have traditionally been treated with simple analgesics, non-steroidal anti-inflammatory drugs, steroids, sulfasalazine, methotrexate, local steroid injections and physiotherapy, but the introduction of biological response modifiers such as tumor necrosis factor-α blockers, has led to further improvements.

AB - Inflammatory bowel diseases (IBDs), particularly Crohn's disease (CD) and ulcerative colitis (UC), are associated with a variety of extra-intestinal manifestations (EIMs). About 36% of IBD patients have at least one EIM, which most frequently affect the joints, skin, eyes and the biliary tract. The EIMs associated with IBD have a negative impact on patients with UC and CD, and the resolution of most of them parallels that of the active IBD in terms of timing and required therapy; however, the clinical course of EIMs such as axial arthritis, pyoderma gangrenosum, uveitis, and primary sclerosing cholangitis is independent of IBD activity. The peripheral and axial arthritis associated with IBD have traditionally been treated with simple analgesics, non-steroidal anti-inflammatory drugs, steroids, sulfasalazine, methotrexate, local steroid injections and physiotherapy, but the introduction of biological response modifiers such as tumor necrosis factor-α blockers, has led to further improvements.

KW - Anti-tumor necrosis factor antagonists

KW - Arthropathies

KW - Inflammatory bowel disease

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=67650133676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650133676&partnerID=8YFLogxK

U2 - 10.3748/wjg.15.2469

DO - 10.3748/wjg.15.2469

M3 - Article

C2 - 19468996

AN - SCOPUS:67650133676

VL - 15

SP - 2469

EP - 2471

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 20

ER -